Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification

被引:9
|
作者
Juan, Conan [1 ]
Bancroft, Alec C. [1 ,2 ]
Choi, Ji Hae [1 ]
Nunez, Johanna H. [1 ]
Pagani, Chase A. [1 ]
Lin, Yen-Sheng [3 ]
Hsiao, Edward C. [4 ,5 ]
Levi, Benjamin [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Ctr Organogenesis Regenerat & Trauma, Dept Surg, Dallas, TX 75390 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Texas Southwestern Med Ctr, Dept Orthopaed Surg, Dallas, TX 75390 USA
[4] Univ Calif San Francisco, Inst Human Genet, Dept Med, Div Endocrinol & Metab,Med Ctr, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Program Craniofacial Biol, Med Ctr, San Francisco, CA 94143 USA
关键词
heterotopic ossification; fibrodysplasia ossificans progressiva; ectopic bone; ACVR2; ALK2; trauma; MESENCHYMAL STEM-CELLS; ECTOPIC BONE-FORMATION; TGF-BETA; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; MAMMALIAN TARGET; OSTEOBLASTIC DIFFERENTIATION; OSTEOCALCIN EXPRESSION; STEM/PROGENITOR CELLS; ALKALINE-PHOSPHATASE;
D O I
10.3390/biom14030349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heterotopic ossification (HO) is a debilitating pathology where ectopic bone develops in areas of soft tissue. HO can develop as a consequence of traumatic insult or as a result of dysregulated osteogenic signaling, as in the case of the orphan disease fibrodysplasia ossificans progressiva (FOP). Traumatic HO (tHO) formation is mediated by the complex interplay of signaling between progenitor, inflammatory, and nerve cells, among others, making it a challenging process to understand. Research into the pathogenesis of genetically mediated HO (gHO) in FOP has established a pathway involving uninhibited activin-like kinase 2 receptor (ALK2) signaling that leads to downstream osteogenesis. Current methods of diagnosis and treatment lag behind pre-mature HO detection and progressive HO accumulation, resulting in irreversible decreases in range of motion and chronic pain for patients. As such, it is necessary to draw on advancements made in the study of tHO and gHO to better diagnose, comprehend, prevent, and treat both.
引用
收藏
页数:27
相关论文
共 50 条
  • [21] Periosteal Pdgfra-lineage cells contribute to heterotopic ossification in Fibrodysplasia Ossificans Progressiva
    Rivera, Loreilys Mejias
    Mourkioti, Foteini
    Shore, Eileen M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 30 - 30
  • [22] Microarchitecture of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva: An HR-pQCT Case Series
    Botman, Esmee
    Bevers, Melissa S. A. M.
    Wyers, Caroline E.
    van Rietbergen, Bert
    Teunissen, Bernd P.
    Raijmakers, Pieter G.
    Netelenbos, Jan Coen
    van den Bergh, Joop P.
    Eekhoff, Elisabeth M. W.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP)
    Hatsell, Sarah
    Huang, Lily
    Aykul, Senem
    Wang, Lili
    Wen, Xialing
    Reisman, Sandra
    Das, Nanditha
    Zhang, Qian
    Lees-Shepard, John B.
    Brydges, Susannah
    Rothman, Nyanza
    Nannuru, Kalyan
    Idone, Vincent
    Schutz, Kevin
    Johnson, Laura
    Murphy, Andrew
    Economides, Aris
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 197 - 197
  • [24] Association of Heterotopic Ossification with Use of Aids, Assistive Devices, and Adaptations in Individuals with Fibrodysplasia Ossificans Progressiva
    Pignolo, Robert J.
    Baujat, Genevieve
    De Cunto, Carmen
    Hsiao, Edward C.
    Keen, Richard
    Al Mukaddam, Mona
    Marino, Rose
    Boing, Elaine A.
    Grandoulier, Anne-Sophie
    Kaplan, Frederick S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 284 - 284
  • [25] Three pairs of monozygotic twins with fibrodysplasia ossificans progressiva: The role of environment in the progression of heterotopic ossification
    Hebela N.
    Shore E.M.
    Kaplan F.S.
    Clinical Reviews in Bone and Mineral Metabolism, 2005, 3 (3-4): : 205 - 208
  • [26] Heterotopic ossification after general surgery in patients with Fibrodysplasia Ossificans Progressiva; A Systematic review.
    Rosenberg, Neeltje M.
    Verheij, Vincent Adriaan
    Burchell, George
    Eekhoff, Elisabeth M. W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 176 - 176
  • [27] Alk2 Regulates Early Chondrogenic Fate in Fibrodysplasia Ossificans Progressiva Heterotopic Endochondral Ossification
    Culbert, Andria L.
    Chakkalakal, Salin A.
    Theosmy, Edwin G.
    Brennan, Tracy A.
    Kaplan, Frederick S.
    Shore, Eileen M.
    STEM CELLS, 2014, 32 (05) : 1289 - 1300
  • [28] HETEROTOPIC OSSIFICATION IN PALOVAROTENE-TREATED AND UNTREATED INDIVIDUALS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: MATCHED AND WEIGHTED ANALYSES
    Al Mukaddam, M.
    Baujat, G.
    Cheung, A. M.
    De Cunto, C.
    Hsiao, E. C.
    Keen, R.
    Marden, J.
    Signorovitch, J.
    Boing, E.
    Marino, R.
    Strahs, A.
    Pignolo, R. J.
    VALUE IN HEALTH, 2023, 26 (06) : S20 - S20
  • [29] RELATIONSHIPS BETWEEN HETEROTOPIC OSSIFICATION VOLUME AND FUNCTIONAL AND QUALITY OF LIFE ENDPOINTS IN FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)
    Verburg-Baltussen, L.
    Dunnewind, N.
    Kroep, S.
    Hout, B., V
    Boing, E.
    Keen, R.
    VALUE IN HEALTH, 2023, 26 (06) : S28 - S29
  • [30] A study of identical twins with fibrodysplasia ossificans progressiva (FOP): The role of environment in the progression of heterotopic ossification.
    Hebela, N
    Shore, EM
    Kaplan, FS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S416 - S416